Home / Inspections / 1019963

1019963

Novocol Pharmaceutical of Canada, Inc. — FEI 3002807757

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge (Canada)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1243223 (VAI Fri May 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117454 (NAI Thu Jan 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1098218 (NAI Fri Jun 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093310 (VAI Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012538 (VAI Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures